Cargando…

Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods

Triple-negative breast cancer (TNBC) poses a significant challenge in terms of prognosis and disease recurrence. The limited treatment options and the development of resistance to chemotherapy make it particularly difficult to manage these patients. However, recent research has been shifting its foc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porta, Francesca Maria, Sajjadi, Elham, Venetis, Konstantinos, Frascarelli, Chiara, Cursano, Giulia, Guerini-Rocco, Elena, Fusco, Nicola, Ivanova, Mariia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381494/ https://www.ncbi.nlm.nih.gov/pubmed/37511789 http://dx.doi.org/10.3390/jpm13071176

Ejemplares similares

Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
por: Ivanova, Mariia, et al.
Publicado: (2023)

Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
por: Sajjadi, Elham, et al.
Publicado: (2023)

Commentary: Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
por: Venetis, Konstantinos, et al.
Publicado: (2021)

Improving HER2 testing reproducibility in HER2-low breast cancer
por: Sajjadi, Elham, et al.
Publicado: (2022)

Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances
por: Ivanova, Mariia, et al.
Publicado: (2023)

HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
por: Sajjadi, Elham, et al.
Publicado: (2021)

Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
por: Sajjadi, Elham, et al.
Publicado: (2020)

Mismatch repair testing in breast cancer: the path to tumor-specific immuno-oncology biomarkers
por: Venetis, Konstantinos, et al.
Publicado: (2020)

HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
por: Ivanova, Mariia, et al.
Publicado: (2022)

Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
por: Sajjadi, Elham, et al.
Publicado: (2022)

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
por: Fusco, Nicola, et al.
Publicado: (2020)

Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
por: Sajjadi, Elham, et al.
Publicado: (2021)

The molecular landscape of breast mucoepidermoid carcinoma
por: Venetis, Konstantinos, et al.
Publicado: (2023)

Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
por: Sajjadi, Elham, et al.
Publicado: (2023)

Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer
por: Venetis, Konstantinos, et al.
Publicado: (2022)

Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
por: Pagni, Fabio, et al.
Publicado: (2019)

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
por: Venetis, Konstantinos, et al.
Publicado: (2021)

PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
por: Lopez, Gianluca, et al.
Publicado: (2020)

Physical Exercise with or without Whole-Body Vibration in Breast Cancer Patients Suffering from Aromatase Inhibitor—Induced Musculoskeletal Symptoms: A Pilot Randomized Clinical Study
por: de Sire, Alessandro, et al.
Publicado: (2021)

Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study
por: Invernizzi, Marco, et al.
Publicado: (2020)

Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
por: Sajjadi, Elham, et al.
Publicado: (2022)

Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
por: de Sire, Alessandro, et al.
Publicado: (2022)

Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study
por: Blundo, Concetta, et al.
Publicado: (2021)

Integrating Biological Advances Into the Clinical Management of Breast Cancer Related Lymphedema
por: Invernizzi, Marco, et al.
Publicado: (2020)

Advances in Early Breast Cancer Risk Profiling: From Histopathology to Molecular Technologies
por: Pescia, Carlo, et al.
Publicado: (2023)

Revolutionizing Cancer Research: The Impact of Artificial Intelligence in Digital Biobanking
por: Frascarelli, Chiara, et al.
Publicado: (2023)

Standard operating procedures for biobank in oncology
por: Bonizzi, Giuseppina, et al.
Publicado: (2022)

Can MRI Biomarkers Predict Triple-Negative Breast Cancer?
por: Moffa, Giuliana, et al.
Publicado: (2020)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher, Brett, et al.
Publicado: (2016)

Triple-negative breast cancer: promising prognostic biomarkers currently in development
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Circulating and tissue biomarkers in early-stage non-small cell lung cancer
por: Fumagalli, Caterina, et al.
Publicado: (2017)

Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
por: Cocco, Stefania, et al.
Publicado: (2020)

Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer
por: Fusco, Nicola, et al.
Publicado: (2016)

Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs)
por: Piga, Isabella, et al.
Publicado: (2023)

Current State and Perspectives in Population Genomics of the Common Bean
por: Cortinovis, Gaia, et al.
Publicado: (2020)

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations()
por: Conforti, Fabio, et al.
Publicado: (2021)

Severe oropharyngeal dysphagia following COVID‐19: a case report
por: De Vincentis, Giulia, et al.
Publicado: (2021)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Current approaches in treatment of triple-negative breast cancer
por: Wahba, Hanan Ahmed, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_al341k4t5596j9lqjfqlrpnls0